Vasculitis Update 2017 CME Course: Chicago, June 24

The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 a.m. – 12:30 p.m. at the Marriott Chicago O’Hare.   Topics will include: utilizing biomarkers and imaging in vasculitis, management of alveolar hemorrhage, and treatment of ANCA associated vasculitis and large vessel vasculitis. 

June 24, 2017
7:45 a.m. – 12:30 p.m.
Marriott Chicago O’Hare
8535 W. Higgins Road
Chicago, Illinois  60631

Sponsored by:

  • Vasculitis Foundation
  • Northwestern University Feinberg School of Medicine Office of Continuing Medical Education
  • Division of Rheumatology, Northwestern University Feinberg School of Medicine
  • Vasculitis Clinical Research Consortium (VCRC)

Audience
This continuing medical education program is designed to meet the educational needs of
physicians who detect, diagnose and treat vasculitis.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Recognize the role of imaging in large vessel vasculitis
  • Summarize treatment for large vessel vasculitis.
  • Interpret evidence for small vessel vasculitis
  • Identify treatment options for alveolar hemorrhage
  • Identify biomarkers for disease prognosis and treatment response

Utilizing Biomarkers in Vasculitis
Sharon Chung, MD, MS
Assistant Professor of Medicine
University of California San Francisco

Imaging in Systemic Vasculitis
Peter Grayson, MD, PhD
Vasculitis Translational Research Program ‐ NIAMS

Management of Alveolar Hemorrhage
Ulrich Specks, MD
Professor of Medicine
Mayo Clinic

Management of ANCA Associated Vasculitis
Peter Merkel, MD, MPH
Professor of Medicine
University of Pennsylvania

Management of Large Vessel Vasculitis
Antoine Sreih, MD
Assistant Professor of Medicine
University of Pennsylvania

Question & Answer Session

Lunch and Learn about the Vasculitis Clinical Research Consortium

Fees
Physician: $150.00
Clinical Staff: $100.00
Trainee: Free

For complete schedule, click here. 

For more information:  312.503.8003

 

Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.


FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »

Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony

On  Thursday, May 18,  Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award.   The VF  nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »


Main Line Health Medical Professional Wins National Award for Early Diagnosis of Rare Disease

The Vasculitis Foundation (VF) announces the winner of its 2017 Recognizing Excellence in Diagnostics (RED) Award.  The V-RED Award is presented annually to a medical professional who made a quick diagnosis of more »

Wisdom of a Ferocious Patient Advocate

Celeste Lee, cherished wife, sister, daughter, mother, faithful friend, and passionate patient advocate, died at age 51 from the autoimmune disease vasculitis, surrounded by family and friends, both near and more »